Introduction
The opportunity of defining precise regions of the herpes simplex virus (HSV) genome involved in pathogenicity has been provided by the isolation of deletion variants of both HSV-1 and -2 (Brown et al., 1984; Harland & Brown, 1985 Brown & Harland 1987; MacLean & Brown, 1987a, b; Efstathiou et al., 1989) . We have recently shown that the JH2604 deletion variant of HSV-2 strain HG52 (Harland & Brown, 1985) is avirulent when inoculated intracerebrally into mice, with an LDso value of > 107 p.f.u./mouse compared to < 102 p.f.u./ mouse for the parental virus (Taha et al., 1989a) . JH2604 has a 1500 bp deletion within both copies of the long repeat region of the genome (TRL and IR0, extending from the 17 bp DRt element of the 'a' sequence to 522 bp upstream of the 5' end of immediate early (IE) gene 1 (Taha et al., 1989b) . JH2604 fails to replicate in mouse brain, does not produce necrotizing encephalitis and the morphological changes induced consist of localized perivascular cuffing by lymphocytes and infiltration by immune cells. Immunohistochemical studies have shown that HSV antigens localize to the site of inoculation with 0000-9898 © 1991 SGM no neuronal involvement (Taha et al., 1990) . Our findings with the JH2604 variant point to sequences within the deleted region having a specific role in vivo and suggest that this region encodes protein. Corroboration of an in vivo function for the terminal sequences of RL came from Thompson et al. (1989) who reported that the HSV-1 strain 17+/HSV-2 strain HG52 recombinant RE6 was avirulent when inoculated intracerebrally into mice and that HSV-1 sequences between map units (m.u.) 0.82 and 0.832 could produce a highly neurovirulent phenotype of RE6.
The identity of a conserved open reading frame (ORF) upstream of IE-1 in HSV-1 Glasgow strain 17 + and HSV-2 strain HG52 is still under analysis (D. J. McGeoch, personal communication). However, Chou & Roizman (1986) have reported that HSV-1 strain F contains a transcribed ORF between the 'a' sequence and IE-1. By the use of antipeptide sera they were able to show that the ORF specified a protein designated ICP34-5 (Ackermann et al., 1986) . This ORF was apparently absent from the strain 17 + sequence . Recently, Chou & Roizman (1990) have reported that their predicted ORF is conserved in two other HSV-1 strains but not in Glasgow strain 17 + .
Here we report the isolation of two Glasgow strain 17 + variants with 759 bp of the published strain 17 wild-type sequence in the terminal portion of RL within BamHI s (0.81 to 0.83 m.u.) deleted. These variants have been characterized in vitro and in vivo and the results demonstrate that sequences within the terminal portion of RL, between IE-1 and the 'a' sequence, confer neurovirulence on Glasgow strain 17 +.
Methods
Cells. Baby hamster kidney clone 13 cells (BHK21/C13) (Macpherson & Stoker, 1962) were propagated in Eagle's medium containing twice the normal concentration of vitamins and amino acids, 5 ~ (v/v) tryptose phosphate broth and 10~ (v/v) calf serum (CS; ETC10).
Viruses. Virus stocks were grown and titrated in BHK21/C13 cells as previously described (Brown et al., 1973) . The parental HSV-I strain was Glasgow strain 17 + (Brown et al., 1973) . The variant 1702, devoid of the four HSV-1 XbaI sites, was the parental virus from which 1714 was isolated (MacLean & Brown 1987a) .
Restriction enzyme analysis of virus genomes. Restriction enzyme analysis was carried out by a modification of the technique of Lonsdale (1979) . BHK21/C13 cells were infected in the presence of 32p i in phosphate-free Eagle's medium containing 1~ (v/v) CS and incubated at 31 °C for 48 h. Viral DNA was extracted with SDS and phenol and ethanol-precipitated. The DNA was treated with various restriction enzymes using the manufacturer's recommended conditions. Digests were analysed by electrophoresis on agarose gels of the appropriate concentrations (0-5 I~o 0.8~) in TBE buffer (89 mM-Tris, 89 mr, i-boric acid, 2 mM-sodium EDTA). Gels were air-dried and exposed to Kodak XS1 film.
DNA-DNA hybridization. DNA fragments from restriction endonuclease digests were transferred from agarose gels to Hybond nylon membranes (Amersham) by the method of Southern (1975) and hybridized with random primed DNA prepared from the BamHI k (s + q) fragment cloned into pAT153. Hybridization was performed at 65 °C in a hybridization buffer containing 7~ SDS and 0.5 M-sodium phosphate buffer (Na2HPO4/NaH2PO4) pH 7 for 16 h; no prehybridization was performed. Filters were washed as described previously (Brown et aL, 1984) .
Animal inoculation. BALB/c mice (3 weeks old) (Bantin & Kingman) were inoculated intracerebrally with individual virus stocks. Mice were anaesthetized with ether and 0.025 ml of the appropriate virus dilution in phosphate-buffered saline (PBS), 5~ CS was inoculated into the central region of the left cerebral hemisphere. Four mice were inoculated with each virus at doses of between 101 and 107 p.f.u./animal. The virus stocks were always re-titrated on the day of inoculation to determine the precise titre inoculated. Mice were observed daily after inoculation and the LD5o was calculated according to the formula of Reed & Muench (1938) on the basis of the number of deaths up to day 21. Brains removed from animals which died postinoculation were homogenized, sonicated and the resulting suspension was titrated on BHK21/C13 cells. Virus plaques were picked and their restriction enzyme profiles determined as described.
Virus growth properties in vitro. BHK21/CI3 (2 x 104) ceils were infected at an m.o.i, of 5 p.f.u./cell. Adsorption was carried out for 45 min at 37 °C and, after two washes with PBS containing 5~ CS and addition of a 2 ml overlay of Eagle's medium containing 10~ CS, incubation was continued at 37 °C. Samples were harvested at 0, 2, 4, 6, g, 12, 16 and 24 h post-infection and virus was released by sonication and titrated at 37 °C.
Thymidine kinase assay. The method used was a modification of that of Jamieson & Subak-Sharpe (1974) . BHK21/C13 cells were mockinfected or infected with wild-type or mutant virus at an m.o.i, of 5 p.f.u./cell. After adsorption for 1 h and incubation for 6 h at 37 °C, the cells were scraped into cold PBS and pelleted. The pellet was resuspended in lysis buffer (20 mM-Tris-HC1 pH 7.5, 2 mM-MgC 12, 10 mM-NaCI, 0.5 ~ v/v NP40, 6.5 mM-2-mercaptoethanol), maintained on ice for 5 min, mixed briefly and replaced on ice for a further 5 min. The samples were centrifuged and the supernatant was retained. Extract (5 ~tl) was mixed with the reaction buffer [0-5 M-Na2PO4 pH 6, 100 rr~-MgC12, 2 mM-dTTP, 100 mM-ATP, 5 ~tl aqueous [Me-3H]thymidine (1 mCi/ml)] in a total volume of 50 lal. After incubating for 1 h, the reaction was stopped by the addition of 10 ktl 100 mM-EDTA and 1 mMthymidine. The samples were heated for 3 min at 100 °C and placed on ice for 3 rain. After centrifugation, the supernatant was spotted onto DE81 discs which were washed three times (10 min each at 37 °C) with 4 mM-ammonium formate pH 6-0 and 10 ~tM-thymidine. After a further two washes with ethanol, the discs were dried and radioactivity due to [3H]thymidine was determined.
Introduction of the deletion into wild-type HSV-1 Glasgow strain 17 +.
To introduce the 1714 deletion into wild-type strain 17 ÷, the cloned, novel BamHI k fragment of 1714 was linearized with BamHI and cotransfected at a 1-, 2-, 5-, 10-and 20-fold molar excess with intact DNA from 17 +. Resulting individual plaques were isolated and their DNA was analysed by the method of Lonsdale (1979) . Virus which appeared to have acquired the deletion was plaque-purified a further three times before a virus stock was grown.
Sequence analysis. The novel BamHI k fragment of 1714 was cloned into the BamHl site of pGEM 3z using standard procedures (Maniatis et aL, 1982) . Positive clones were identified by restriction enzyme analysis and confirmed by Southern blotting of total HSV-1 DNA and using random primed DNA from the positive clones. Further restriction enzyme analysis confirmed that the deletion was approximately 800 bp in size and was located within a 2.8 kb AluI fragment. This fragment was eluted from a gel, digested with SmaI and several small fragments were subcloned into M13mp8. Single-stranded template DNA was prepared and sequenced using 3sS-labelled dATP by the method of Sanger et al. (1980) . The sequencing products were run on a 6~ acrylamide, 1 x TBE, 8-3 M-urea gel.
Latency studies. BALB/c mice (3 weeks old) (Bantin & Kingman) were inoculated in the right rear footpad as described previously (Clements & Subak-Sharpe, 1983 . At the time of inoculation the virus was titrated on BHK21/C13 cells to quantify the precise dose administered. For each virus, a series of 100-fold dilutions was inoculated and mice were examined and scored daily for clinical symptoms. Mice surviving 6 weeks were examined for the presence of latent virus. The mice were killed and dissected and the two lowest thoracic, six lumbar and the upper two sacral ganglia were removed from the inoculated side, placed in culture medium and screened for release of infectious virus every second day by transferring the culture medium to control BHK21/C13 cells. The inoculated BHK21/C13 ceils were incubated at 37 °C for 2 days before staining and examination for the presence of virus plaques or c.p.e.
Results

Isolation and genome analysis of the variant 1714
To study recombination in HSV we have constructed viruses devoid of certain restriction enzyme sites which Brown, 1987c).] are to be used as unselected markers (Brown et al., 1984; Harland & Brown, 1985; MacLean & Brown, 1987c) . The HSV-1 strain 17 + mutant, 1702 (MacLean & Brown, 1987 c) (devoid of the four HSV-1 XbaI sites and tk-), was the parental virus used to remove various HindlII sites by site-directed mutagenesis. D N A from the virus isolate HI, derived from 1702 but lacking the 0.91 m.u. HindlII site, was cotransfected with a mutagenized plasmid devoid of the 0.18 m.u. HindlII site. A large number of resulting progeny plaques were picked and their D N A was subjected to restriction enzyme analysis. In addition to successfully isolating a desired mutant in which the 0.18 m.u. HindlII site had been lost, a virus (1714) with aberrant restriction enzyme profiles unrelated to the loss of HindlII sites was detected.
On KpnI digestion of 1714 DNA, the KpnI r (Mr 2.4 x 106) fragment was found to be missing ( Fig. la) and a novel band of about Mr 1.9 x 106 was seen running between fragments t and u. The KpnI r fragment is the terminal portion of RL (0 to 0.025 m.u. and 0.805 to 0.83 m.u.) and forms the joint fragments a (r + j ) and e (r + k). It can be seen that the 1714 e fragment ran marginally faster than the equivalent wild-type fragment but no alteration in the a fragment, which runs at the top of the gel, can be seen. Similarly, the HpaI m (Mr 3"6 x 106) fragment was missing ( Fig. 1 b) and a novel band of approximate Mr 3"1 x 106 was detectable running below (Fig. lc) , the BamHI s (Mr 1"95 × 10 6 ) fragment was missing from the restriction pattern and a new band appeared to be running below the u/v fragments with an Mr of about 1-45 x 106. The BamHI s fragment containing joint fragment k (s + q) was also undetectable but a novel band with an Ms of 3.5 × 10 6, which was presumed to be the deleted joint, was seen below the l fragment. Taken together, the restriction enzyme profiles indicated that 1714 was deleted in both copies of the terminal portion of RE between 0 and 0.095 m.u. and 0.81 and 0.83 m.u. The size of the deletion was estimated to be between 600 and 800 bp. To confirm that sequences were lost from both copies of RE, Southern blot analysis of 1714 D N A was carried out. S t r a i n 17 + and 1714 DNAs were digested with BamHI and transferred to a nitrocellulose membrane. The BamHI k fragment (s + q) of 17 + D N A was randomly primed and hybridized to the digested DNA. It can be seen (Fig. 2 ) that in the 17 + sample, the probe hybridized to fragments k, q and s. In 1714, the probe failed to hybridize to fragment k but hybridized to a novel k fragment, a novel k fragment with additional 'a' sequences and fragment q. There was no hybridization to fragment s but the probe did hybridize to a novel s fragment running below it. Incorporation of a size ladder demonstrated the deletion to be about 800 bp in length. This result unambiguously demonstrates that 1714 was deleted in both copies of RL and that the deletion was contained within BamHI s.
Sequence analysis
The BamHI k joint fragment (s + q) of strain 17 is located between nucleotides 123459 and 129403 strain 17 starts at nucleotide position 125954. In 1714, one complete 18 bp DR1 element (AGCCCGGGC-CCCCCGCGG) of the 'a' sequence has been precisely removed (Fig. 3) .
Neurovirulence of the deletion variant 1714for BALB/c mice
We have previously shown that the deletion variant JH2604 of HSV-2 strain HG52 is non-neurovirulent for BALB/c mice with an LDs0 value of > 107 p.f.u./mouse compared to < l02 p.f.u./mouse for the wild-type virus. Sequence analysis of JH2604 demonstrated that a 1488 bp sequence within the terminal portion of the genome R E (between 0 and 0-02 m.u. and 0-81 and 0.83 m.u.) conferred neurovirulence on HSV-2 strain HG52. As 1714 had a deletion in the equivalent parts of the HSV-1 genome, experiments to determine the neurovirulence of 1714 compared to its parent 1702 and to HSV-1 strain 17 + by estimation of their LDso values in BALB/c mice were carried out. Aliquots (25 txl) of different doses of 17 +, 1702 and 1714 were inoculated into the left cerebral hemisphere of 3-week-old BALB/c mice. Deaths from encephalitis were scored up to day 21 postinoculation and the results are shown in Table 1 . The elite laboratory stock of 17 + showed an LDso value of <101"5 p.f.u./mouse. The mutant 1702, although tk-(MacLean & Brown, 1987a) gave a marginally higher LDso value of 5 x 102 p.f.u./mouse. With 1714 no animals died with an inoculum of 106 p.f.u./mouse but three of four died with 107 p.f.u., giving an LDs0 value of 7 x 106 p.f.u./mouse. Thus the deletion variant 1714 was at least 2 x 104-fold less neurovirulent than the parental 1702 virus and at least 7 x 10S-fold less so than the wildtype 17 +. Single plaques were isolated from the brains of 1714-infected mice which had died and the DNA of the plaque isolates was digested with restriction enzymes. The restriction enzyme profiles obtained were identical to that of 1714, indicating that there was no wild-type contamination. The particle p.f.u. ratios of 72:1 for 17 + and 58:1 for 1714 are comparable and fall within the normal range of values for HSV-1. 
Growth of 1714 in vivo
The HSV-2 strain HG52 variant JH2604 was shown to be avirulent by its failure to replicate in mouse brain or to produce necrotizing encephalitis (Taha et al., 1990) . To determine whether the absence of neurovirulence of 1714 was also due to its failure to replicate in mouse brain, samples of 17 + (102 p.f.u.), 1702 (102 p.f.u.) and 1714 (105 p.f.u.) were inoculated into the left cerebral hemisphere of 3-week-old BALB/c mice. At various times postinoculation two mice (per virus) were killed and their brains were removed and frozen at -70 °C. The brain tissue was homogenized, the resulting suspension sonicated and the progeny virus assayed by plaque titration on BHK21/C13 cells at 37 °C. The results, plotted in Fig.  4 , show that for the parental strain 17 there was exponential growth of virus between 12 h and day 6 postinoculation, reaching a final titre of 8 x 106 p.f.u./brain. Likewise, with 1702, virus was detectable 24 h postinoculation and exponential growth of virus reaching a titre of 8 x 104 p.f.u./brain by 6 days post-inoculation was seen. In the 1714-infected animals, which had received an input dose of 10 s p.f.u., 2 x 103 p.f.u, virus could be detected immediately post-inoculation. No replication was detectable and the input virus declined until by 3 days post-inoculation there was no assayable virus (< 10 p.f.u.).
Growth of 1714 in vitro
The variant 1714 grows to high titre (> 109 p.f.u.) by multicycle growth following low multiplicity infection of B HK21/C 13 cells. The stock gives equivalent titres when assayed at 31 °C, 37 °C and 38-5 °C. To determine its growth pattern, single-cycle growth experiments were carried out in BHK21/C13 cells at 37 °C. Results are given in Fig 5 (a) and itcan be seen that 17 + and the 1702 and 1714 variants grew equally well, giving equivalent final yields. The normal single-cycle growth pattern of 1714 indicates no impairment of any stage in its replicative cycle in BHK21/C13 cells.
To determine whether the virus was host-restricted, 24 h yield experiments were carried out in a range of cell tines infected at an m.o.i, of 5 p.f.u./cell. The cell lines used were BHK21/C 13 (hamster), BSC1 (monkey), Vero (monkey), MDCK (dog), HFL (human) and 3T6 (mouse). The 24 h yields in BHK21/C13 cells titrated at 37 °C are shown in Table 2 as are the ratios of the yields of virus grown in a particular cell line compared to the yield in BHK21/C13 cells. It can be seen that 17 +, 1702 and 1714 behave essentially in a similar fashion; they grew equally well in BHK21/C13, 3T6 and MDCK ceils, better in Vero cells and less well in HFL and in BSC1 cells. Note that there was no replication defect in the mouse 3T6 cells, demonstrating that the lack of growth in vivo was not species-specific.
Latency studies
BALB/c mice (3 weeks old) were inoculated in the right rear footpad with serial 10-fold dilutions of 17 +, 1702 and 1714 (four mice/dose) and were monitored daily for 2 weeks for signs of illness or death. At 6 weeks postinoculation, surviving mice were dissected as outlined in Methods and ganglia were separately transferred to microtitre wells containing culture medium. Screening for the presence of infectious virus was carried out every second day post-explantation by transferring an aliquot of culture medium to control BHK21/C 13 ceils. Virus first reactivated at day 6 post-explantation and there was no significant difference in the timing of reactivation between the three viruses; reactivation was confined to the lumbar ganglia in the three groups of mice. Taking into account the tk-phenotype, the variant 1714, although capable of latency, was much less efficient than 1702 in establishing the latent state and/or reactivating from it following explantation. Virus recovered from ganglia had its DNA structure confirmed by restriction enzyme analysis.
Introduction of the 1714 deletion into the 17 + wild-type genome
As the 1714 deletion was not in a wild-type background, i.e. the four XbaI sites at 0-07, 0.29, 0.45 and 0.63 m.u. were deleted from the genome and the virus was tk-, it was conceivable that its avirulent phenotype was at least in part due to these other mutations. However, this seemed very unlikely because the parent strain, 1702, which contains the same XbaI-negative and tk-mutations, showed virulence which was essentially equivalent to that of 17 + . Nonetheless we decided to introduce the deletion in 1714 into an otherwise totally wild-type genome. 17 + DNA was cotransfected with a 10-fold excess of plasmid-cloned BamHI k fragment from 1714. Resultant single progeny plaques were isolated and their DNA profiles analysed by the method of Lonsdale (1979) . A virus with a 1714 BamHI profile, designated 1716, was isolated, plaque-purified a further three times and a virus stock was grown. To confirm that 1716 had retained its wild-type background in respect of XbaI sites and tk activity, the DNA of 1716 was digested with XbaI and a tk assay was performed. It can be seen in Fig. 6 that 1716 has a normal wild-type XbaI profile, retaining the four sites in UL, whereas 1714 and 1702 could not be digested with XbaI. The results of the tk assay for 1716 (131987 c.p.m./p.g protein) compared to those for 17 ÷, Table 3 . It can be seen that it is nonneurovirulent with an LD50 value of 7 x 106 p.f.u./mouse whereas, in this experiment, 17 ÷ had an LDs0 value of <I0 p.f.u./mouse confirming that the sequences deleted in 1716 confer neurovirulence on strain 17 +.
Results of a single-cycle growth experiment with 1716 (Fig. 5b) show that 1716 grows as efficiently as wildtype 17 + virus. The latency potential of 1716 is under analysis.
Discussion
This paper reports the isolation from transfected DNA, and the characterization of an apparently spontaneous deletion variant of HSV-1 Glasgow strain 17 +. The variant 1714 had as its parent the variant 1702, in which the four XbaI sites had been deleted in addition to having a tk-phenotype. Restriction enzyme and Southern blot analysis showed that 1714 had a deletion of approximately 800 bp within the 3 kb B a m H I s fragment (0 to 0.02 and 0.81 to 0.83 m.u.); dideoxynucleotide sequence analysis showed that the deletion is 759 bp in length within both copies of the B a m H I s fragment. In IRL it extends from nucleotide 125213, which is 1105 bp upstream from the 5' end of IE-1, to nucleotide 125972, ending by the removal of one complete copy of the 18 bp DR1 element of the 'a' sequence. This is a remarkable finding in that the 1488 bp deletion in the HSV-2 HG52 variant JH2604 terminated similarly, taking out one complete 17 bp copy of the DR1 element. As the HSV-1 and HSV-2 sequences are not homologous, it follows that the precise excision point cannot be related to the nucleotide sequences per se but may relate to some functional aspect of the 'a' sequence. The reason for a defined break point between the DR~ and Us elements of the 'a' sequence is now under experimental investigation.
When HSV invades the central nervous system and causes disease, the commonest outcome is a fatal encephalitis. It is therefore of crucial importance to define genes or regions of the genome which confer a neuropathogenic phenotype. Various laboratories have predominantly implicated the viral sequences between 0.7 and 0.83 m.u. in the control of neurovirulence. In HSV-2 strain HG52, this genome component was defined more precisely by locating the relevant sequences within a 1488 bp subfragment of the terminal portion of RL between the 'a' sequence and a site 500 bp upstream of IE-1 (Taha et al., 1989b) . Chou & Roizman (1986) reported that HSV-1 strain F contains a transcribed ORF situated in RL between the 'a' sequence and IE-I. By means of an antibody produced against tandem repeats of the trimer Ala-Thr-Pro, predicted to be specified by the ORF, it was shown that the ORF specified a protein designated ICP34.5 (Ackermann et al., 1986) . In HSV-1 strain 17 +, the ORF ascribed to ICP34.5 was thoroughly disrupted . Chou & Roizman (1990) have reported that the ORF they identified is conserved in two other HSV-1 strains but not in strain 17 ÷, attributing this to the alleged multipassage history of strain 17 ÷ having led to the accumulation of mutations. Their analysis, which corrected 25 sequencing mistakes in their 1986 paper, if correct, predicts that if the ORF is not conserved in strain 17 ÷ and the deduced protein is A. R. MacLean and others not made, then strain 17 + should at least be modified in its neurovirulence if not totally avirulent. However, this is not so; strain 17 + is highly neurovirulent. The fortuitous isolation of a spontaneous deletion variant of strain 17 + with a 759 bp deletion in both copies of RL, extending from the 'a' sequence to 1105 bp upstream of IE-1, has now provided proof that sequences in a similar genomic location in both HSV-1 strain 17 + and HSV-2 strain HG52 produce neurovirulence.
As a basis for studying biological properties such as latency and virulence of defined deletion variants in animal model systems, it is essential to determine the phenotype of the parental wild-type virus. We have recently shown in HSV-2 strain HG52 that there is marked heterogeneity in virulence within the original unselected wild-type virus stock, with LDs0 values on intracerebral inoculation ranging from < 103 to 3 x 105 p.f.u./mouse (Taha et al., 1988) . However, on assessing the virulence values of individual plaque stocks of HSV-1 strain 17 + , no similar heterogeneity has been identified, with LDs0 values showing at most a fivefold variation (our unpublished results). The elite stock of HSV-1 strain 17 + is highly virulent on intracerebral inoculation of mice, with an LDs0 of <10 p.f.u./mouse. The 1702 parent of 1714 has an LD50 of 5 x 102 p.f.u./mouse, indicating an assumed effect of its tk-phenotype on neurovirulence. The LD5o of 1714 is 7 x 106 p.f.u./ mouse, based on the fact that no mice died at an inoculating dose of 106 but three of four died when 107 p.f.u, was administered directly to the brain. Owing to the virus titre and inoculum required, undiluted virus was injected into the 10 v p.f.u.-infected animals. The three mice which died did so between 24 and 36 h postinoculation and it is suspected that death was due to the large antigen load and not to virus replication and encephalitis. Mice which die from encephalitis normally start showing symptoms about 72 h post-inoculation and die fairly soon afterwards. The appearance of the animals is also different. Therefore, it is concluded that 1714 is not neurovirulent for mice and that the deleted DNA sequences specify (wholly or partly) a virus function required for neurovirulence. Construction of the 1716 recombinant substantiates this conclusion in that its LDso is 7 x 106 p.f.u./mouse and rules out involvement of the XbaI sites or tk in this neurovirulence phenotype. We have shown, therefore, that Glasgow strain 17 + is highly neurovirulent and the isolation of deletion variants 1714 and 1716 identifies the location of the sequences specifying a HSV neurovirulence function. indicated that their sequence analysis was consistent with there being protein coding sequences in the region of the genome upstream of IE-1 but they were not prepared to propose any definite gene layout. Recent comparison of the equivalent region of the genome of HSV-2 strain HG52 points to a 1.89 bp conserved sequence in HG52 and HSV-1 strain 17 (D. J. McGeoch, personal communication). The precise endpoints of the neurovirulence gene have not yet been resolved and the identity of a specified polypeptide is under analysis. In the HG52 JH2604 deletion variant, the whole 63 amino acid coding sequence is removed together with the upstream sequences as far as the 'a' sequence. In 1714 and 1716, 107 bp of the 5' part of the conserved sequence is deleted plus the upstream sequences extending as far as those in JH2604. The deletions in both the HSV-1 and HSV-2 variants remove the putative initiation codons proposed by Chou & Roizman (1990) . Whatever the final resolution of a defined gene in this region of the HSV genome, it seems Clear that the function of its specific protein is in neurovirulence.
It appears that the avirulence of 1714 and 1716 is due to an inability to replicate within the central nervous system as a direct consequence of the loss of 759 bp within the terminal portion or RL. The candidate target cells in the central nervous system are neurons and it is supposed that the replication defect is only manifest in the central nervous system neuron environment and may be related to one or more of the following: adsorption/ penetration, a neuron-required transcription factor, a block in DNA replication in neurons, or a cleavagepackaging defect. As 1714 is capable of establishing a latent infection in dorsal root ganglia, it is assumed that the virus is latent in neuronal cells of the spinal ganglia. In normal wild-type infections of the mouse, the nature of the relationship between HSV and peripheral nervous system neurons is different to that between HSV and central nervous system neurons. It is concluded that the ability of 1714 to develop a lytic infection in central nervous system tissue has been destroyed but its latency potential is retained. The nature of the replication defect is under analysis. (Received 27 August 1990; Accepted 29 November 1990) 
